CS
Christopher M Starr (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Monopar Therapeutics Inc. (MNPR). The largest single filing was $596K of MNPR (7,601 sh across 2 lots, as filed), executed Oct 1. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$596K
shares × price, as filed
Last traded
Oct 1
Filed Oct 5
Median ADV $24.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
MNPRRecent filings
MNPRSALE
Monopar Therapeutics Inc.
View filing →
$596K7,601 sh across 2 lots
Exec Oct 1
Filed Oct 5 · 5:43 PM ET MNPRSALE Monopar Therapeutics Inc. View filing → $672K
16,800 sh × $40.00
Exec Jul 14 2025
Filed Jul 16 2025 · 5:30 PM ET